Evidence map›Paper›PMID 39501020›Full record

ArticleScientific reports2024

Assessing the ability of GPT-4o to visually recognize medications and provide patient education.

Amjad H Bazzari, Firas H Bazzari

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Amjad H BazzariDepartment of Basic Scientific Sciences, Faculty of Science, Applied Science Private University, Amman, 11931, Jordan. a_bazzari@asu.edu.jo.
Firas H BazzariFaculty of Pharmacy, Jerash University, Jerash, 26150, Jordan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Various studies have investigated the ability of ChatGPT (OpenAI) to provide medication information; however, a new promising feature has now been added, which allows visual input and is yet to be evaluated. Here, we aimed to qualitatively assess its ability to visually recognize medications, through medication picture input, and provide patient education via written and visual output. The responses were evaluated by accuracy, precision and clarity using a 4-point Likert-like scale. In regards to handling visual input and providing written responses, GPT-4o was able to recognize all 20 tested medications from packaging pictures, even with blurring, retrieve their active ingredients, identify formulations and dosage forms and provide detailed, yet concise enough, patient education in an almost completely accurate, precise and clear manner with a score of 3.55 ± 0.605 (85%). In contrast, the visual output through GPT-4o generated images illustrating usage instructions contained many errors that would either hinder the effectiveness of the medication or cause direct harm to the patient with a poor score of 1.5 ± 0.577 (16.7%). In conclusion, GPT-4o is capable of identifying medications from pictures and exhibits contrasting patient education performance between written and visual output with very impressive and poor scores, respectively.

Indexed as

Patient Education as TopicFemaleHumansMalePharmaceutical PreparationsPharmaceutical Preparations

Identifiers

PMID39501020
PMCPMC11538418

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.